Table 1 |
||||||||
|
|
||||||||
|
Disease group |
||||||||
|
|
||||||||
|
Healthy controls |
Systemic lupus erythematosus |
Rheumatoid arthritis |
Inflammatory disease |
|||||
|
|
|
|
|
|||||
|
Mean |
SEM |
Mean |
SEM |
Mean |
SEM |
Mean |
SEM |
|
|
|
||||||||
|
PD-1+ (%) |
||||||||
|
in CD3+ |
0.6 |
0.2 |
0.4 |
0.1 |
1.6 |
0.6 |
0.5 |
0.1 |
|
in CD19+ |
1.7 |
0.9 |
1.4 |
0.3 |
0.9 |
0.4 |
1.1 |
0.4 |
|
in CD25+ |
3.0 |
1.0 |
2.4 |
0.7 |
3.3 |
1.6 |
8.5 |
3.4 |
|
PD-L1+ (%) |
||||||||
|
in CD3+ |
2.8 |
1.2 |
4.1 |
0.9 |
2.3 |
0.5 |
2.0 |
0.6 |
|
in CD19+ |
3.9 |
1.3 |
5.1 |
0.9 |
3.7 |
1.0 |
11.3 |
8.0 |
|
in CD14+ |
5.1 |
2.0 |
14.0 |
5.4 |
2.9 |
0.9 |
5.7 |
3.2 |
|
PD-L2+ (%) |
||||||||
|
in CD3+ |
0.6 |
0.2 |
0.5 |
0.1 |
0.5 |
0.2 |
0.4 |
0.0 |
|
in CD14+ |
2.0 |
0.5 |
1.4 |
0.3 |
1.1 |
0.5 |
1.2 |
0.1 |
|
|
||||||||
|
SEM, standard error of the mean. No statistically significant differences were observed. |
||||||||
|
Bertsias et al. Arthritis Research & Therapy 2005 7(Suppl 1):P153 doi:10.1186/ar1674 |
||||||||